Aaron L Sverdlov
Overview
Explore the profile of Aaron L Sverdlov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mecinaj A, Vinje-Jakobsen V, Ngo D, Sverdlov A, Myhre P
Heart Fail Rev
. 2025 Feb;
PMID: 39960554
This mini-review highlights the results of the SARAH trial, which evaluated the efficacy of sacubitril/valsartan in preventing subclinical cardiac dysfunction in patients undergoing anthracycline-based chemotherapy. The trial demonstrated a significant...
2.
Kelly C, Kiltschewskij D, Leong A, Haw T, Croft A, Balachandran L, et al.
Sci Rep
. 2025 Feb;
15(1):4395.
PMID: 39910168
Cancer therapy-related cardiovascular toxicity (CTR-CVT) is now recognised as one of the leading causes of long-term morbidity and mortality in cancer patients. To date, potential overlapping cardiotoxicity mechanism(s) across different...
3.
Jones T, Edbrooke L, Rawstorn J, Denehy L, Hayes S, Maddison R, et al.
JMIR Cancer
. 2024 Dec;
10:e51536.
PMID: 39697144
Background: Strong evidence supports the benefits of exercise following both cardiovascular disease and cancer diagnoses. However, less than one-third of Australians who are referred to exercise rehabilitation complete a program...
4.
Butel-Simoes L, Ngo D, Sverdlov A
Eur Heart J
. 2024 Dec;
46(3):285-287.
PMID: 39680373
No abstract available.
5.
Sritharan S, Wilsmore B, Wiggers J, Butel-Simoes L, Fakes K, McGee M, et al.
JACC Adv
. 2024 Oct;
3(11):101328.
PMID: 39469611
Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality and residing in a rural and remote region is associated with an increased risk. The impact of rurality...
6.
Liu S, Horowitz J, Koczwara B, Sverdlov A, Packer N, Clark R
Cardiooncology
. 2024 Oct;
10(1):72.
PMID: 39415228
Background: The association between cardiovascular disease and carcinogenesis is bidirectional and well-established. Furthermore, cancer treatment improves overall patient survival, potentially at the cost of incremental and fatal cardiovascular disease (CVD)....
7.
Litwin S, Komtebedde J, Borlaug B, Kaye D, HasenfuB G, Kawash R, et al.
Am Heart J
. 2024 Sep;
278:106-116.
PMID: 39237070
Background: There is a little evidence regarding long-term safety and efficacy for atrial shunt devices in heart failure (HF). Methods: The REDUCE LAP-HF I (n = 44) and II (n...
8.
Ferreira D, Mikhail P, Lim J, Ray M, Dwivedi J, Brienesse S, et al.
JACC Clin Electrophysiol
. 2024 Sep;
10(10):2207-2213.
PMID: 39230541
Background: Direct current cardioversion is frequently used to return patients with atrial fibrillation (AF) to sinus rhythm. Chest pressure during cardioversion may improve the efficacy of cardioversion through decreasing transthoracic...
9.
Marwick T, Dewar E, Nolan M, Shirazi M, Dias P, Wright L, et al.
Eur Heart J
. 2024 Sep;
45(41):4414-4424.
PMID: 39217601
Background And Aims: The detection of cancer therapy-related cardiac dysfunction (CTRCD) by reduction of left ventricular ejection fraction (LVEF) during chemotherapy usually triggers the initiation of cardioprotective therapy. This study...
10.
Keramida K, Farmakis D, Rakisheva A, Tocchetti C, Ameri P, Asteggiano R, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2077-2093.
PMID: 39193837
No abstract available.